Recall: Accord Hydrochlorothiazide Tablets USP 12.5 Mg
On 2018-08-27, the FDA announced that Accord Healthcare is conducting a recall on Hydrochlorothiazide Tablets USP 12.5 Mg due to a possible labeling mix-up. The recalled products were sold under the brand name(s) Accord during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential labeling mix-up. Additionally, there have been 27 drug and medical device recalls due to other health hazards as well as 69 food recalls.

Company Contact Information:
Name: Accord Healthcare
Phone: 1-855-869-1081
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Hydrochlorothiazide Tablets USP 12.5 mg
Brand Name(s): Accord
Reason for Recall: Labeling mix-up/may contain Spironolactone Tablets
Official Recall Date: 2018-08-27
Additional information provided by the FDA.gov:
Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 - 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level. Read More.
More information may be available at FDA.gov
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.
Comments